This goes back to the same question I have repeatedly raised regarding these deals. What role does GNBT play in these deals and the development of the vaccine. If NGIO develops the vaccine and sells the vaccine the only benefit to GNBT is that the value of NGIO goes up.

But if GNBT is acting as a broker of sorts or supplying supply logistics, etc then there should be a % due to GNBT.

Side note this is why I don’t like the same management team running both ships.